Long-term risk of adverse outcomes according to atrial fibrillation typeSteffen Blum, Drahomir Aujesky, Stefanie Aeschbacher et al.|Scientific Reports|2022Cited by 20
Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter DefibrillatorsJuhani Junttila, Stefan Stefanow, Marc A. Vos et al.|Diabetes Care|2019Cited by 16
Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillationSteffen Blum, Elisavet Moutzouri, Stefanie Aeschbacher et al.|Heart Rhythm|2020Cited by 15
Heart rate variability and stroke or systemic embolism in patients with atrial fibrillationPeter Hämmerle, Juerg Fuhrer, Stefanie Aeschbacher et al.|Heart Rhythm|2024Cited by 15